Verqalif 2.5 mg/5 mg/10 mg Film-Coated Tablets

    Verqalif 2.5 mg/5 mg/10 mg Film-Coated Tablets

    S4

    API: Vericiguat | Company: Bayer

    1. What VERQALIF is and what it is used for

    VERQALIF contains the active substance vericiguat, which is a type of heart medicine called soluble guanylate cyclase stimulator.

    VERQALIF is used to treat adults with long-term heart failure who recently have had an increase in heart failure symptoms. Therefore, you may have gone to hospital and/or received a medicine (diuretic) given in a vein to help you pass more urine than usual.

    Heart failure is when your heart is weak and cannot pump enough blood to your body. Some common symptoms of heart failure are shortness of breath, tiredness, or swelling caused by a build-up of fluid.

    2. What you need to know before you take VERQALIF

    Do not take VERQALIF:

    • if you are hypersensitive (allergic) to vericiguat or any of the other ingredients of VERQALIF,
    • if you are taking any medicine that contains another soluble guanylate cyclase stimulator, e.g. riociguat used to treat high blood pressure in the lungs.

    If any of the above applies to you, talk to your doctor first and do not take this medicine.

    Warnings and precautions

    Talk to your doctor or pharmacist before taking VERQALIF.

    • if you have low blood pressure with symptoms like dizziness or light-headedness,
    • if you have severe kidney problems or are on dialysis,
    • if you have severe liver problems.

    Children and adolescents

    Do not give VERQALIF to children and adolescents aged under 18 years because it has not been studied yet in this age group.

    Other medicines and VERQALIF

    Always tell your healthcare professional if you are taking, have recently taken or might take any other medicines (including complementary or traditional medicines), in particular medicines that:

    • belong to the group of soluble guanylate cyclase stimulators (e.g. riociguat; medicine used for high blood pressure in the lungs). Do not take VERQALIF when taking these medicines. See “Do not take VERQALIF”.
    • treat high blood pressure in the lungs, or medicines to achieve or maintain an erection, called PDE5 inhibitors (e.g. sildenafil, tadalafil, vardenafil). The use of these medicines is not recommended when taking VERQALIF.
    • treat heart disease including chest pain, called nitrates (e.g. isosorbide mononitrate).

    Pregnancy and breastfeeding and fertility

    If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking VERQALIF.

    Pregnancy

    VERQALIF should not be used during pregnancy, as it is not known if it harms the unborn baby. If there is a chance that you could become pregnant, talk to your doctor about reliable forms of contraception.

    Breastfeeding

    It is not known if VERQALIF passes into your breast milk and could harm your baby. Your doctor will decide with you whether breastfeeding or VERQALIF therapy should be stopped.

    Driving and using machines

    If you feel dizzy while taking VERQALIF, do not drive a vehicle, cycle, or use any machines.

    3. How to take VERQALIF

    Always take VERQALIF exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

    The recommended starting dose is 1 tablet of 2.5 mg once daily. Your doctor will then adjust the dose depending on how well the treatment is tolerated. Typically, your doctor will increase the dose after about 2 weeks to 1 tablet of 5 mg once daily and after about another 2 weeks up to the maximum target dose of 1 tablet of 10 mg once daily.

    If you have low blood pressure while taking VERQALIF, this can make you feel dizzy and light-headed and your doctor may temporarily reduce your VERQALIF dose or interrupt your treatment with VERQALIF.

    Take one tablet at the same time each day with food.

    If you cannot swallow the tablet, you may crush VERQALIF and mix it with water. Take this mixture immediately.

    If you take more VERQALIF than you should

    Contact your doctor immediately if you take more VERQALIF than you should, and you get any side effects listed in section 4. The most likely effect would be a lowering of your blood pressure which can make you feel dizzy and light-headed.

    In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison centre.

    If you forget to take VERQALIF

    Take the missed tablet as soon as you remember on the same day of the missed dose. Do not take a double dose to make up for a forgotten tablet.

    If you stop taking VERQALIF

    Do not stop taking this medicine without speaking with your doctor first. If you stop taking this medicine, your condition may worsen.

    If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

    4. Possible side effects

    VERQALIF can have side effects. Not all side effects reported for VERQALIF are included in this leaflet. Should your general health worsen or if you experience any untoward effects while taking VERQALIF, please consult your doctor, pharmacist, or other healthcare professional for advice.

    The possible side effects are:

    Most frequent (may affect more than 1 in 10 people)

    • low blood pressure (hypotension)

    Frequent (may affect up to 1 in 10 people)

    • low number of red blood cells (anaemia), which can cause pale skin, weakness or breathlessness
    • dizziness
    • headache
    • nausea and vomiting
    • indigestion (dyspepsia)
    • heartburn (gastro-oesophageal reflux disease)

    If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

    Reporting of side effects

    If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects to SAHPRA via the “6.04 Adverse Drug Reaction Reporting Form”, found online under SAHPRA’s publications: https://www.sahpra.org.za/Publications/Index/8. By reporting side effects, you can help provide more information on the safety of VERQALIF.

    5. How to store VERQALIF

    Keep this medicine out of the sight and reach of children.

    Do not use this medicine after the expiry date which is stated on the carton and on each blister after “EXP”. The expiry date refers to the last day of that month.

    Store VERQALIF at or below 30 °C.

    Do not dispose of unused medicines in drains or sewerage system (e.g. toilets). Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

    Important Disclaimer

    The Verqalif 2.5 mg/5 mg/10 mg Film-Coated Tablets professional information leaflet below is the property of Bayer and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Verqalif 2.5 mg/5 mg/10 mg Film-Coated Tablets
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites